Regenxbio Inc (NASDAQ:RGNX)

30.24
Delayed Data
As of 3:59pm ET
 -0.81 / -2.61%
Today’s Change
27.02
Today|||52-Week Range
50.26
-33.33%
Year-to-Date

Today’s Trading

Previous close31.05
Today’s open31.23
Day’s range30.06 - 31.42
Volume13,528
Average volume (3 months)436,535
Market cap$1.3B
Data as of 3:59pm ET, 11/29/2021

Growth & Valuation

Earnings growth (last year)-15.57%
Earnings growth (this year)+230.60%
Earnings growth (next 5 years)+11.81%
Revenue growth (last year)+338.70%
P/E ratioNM
Price/Sales10.94
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
QUREUniqure NV-0.31-1.07%
MORMorphoSys AG+0.11+1.11%
REPLReplimune Group Inc-0.40-1.38%
OCGNOcugen Inc+0.03+0.46%
Data as of 4:52pm ET, 11/29/2021

Financials

Next reporting dateMarch 2, 2022
EPS forecast (this quarter)$6.79
Annual revenue (last year)$154.6M
Annual profit (last year)-$111.3M
Net profit margin-71.98%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts